| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.091 | 0.002 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.005 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.006 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.006 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.084 | 0.006 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.007 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.007 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.096 | 0.007 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.13 | 0.008 |